X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PLETHICO PHARMA TTK HEALTHCARE/
PLETHICO PHARMA
 
P/E (TTM) x 22.0 -1.1 - View Chart
P/BV x 7.4 0.0 44,250.1% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 TTK HEALTHCARE   PLETHICO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PLETHICO PHARMA
Mar-14
TTK HEALTHCARE/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs663395 168.0%   
Low Rs39931 1,274.8%   
Sales per share (Unadj.) Rs535.6604.4 88.6%  
Earnings per share (Unadj.) Rs15.932.5 49.1%  
Cash flow per share (Unadj.) Rs20.051.3 39.0%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.6473.6 29.1%  
Shares outstanding (eoy) m7.7734.08 22.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.4 281.3%   
Avg P/E ratio x33.36.6 507.7%  
P/CF ratio (eoy) x26.54.2 638.9%  
Price / Book Value ratio x3.90.5 857.8%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1277,262 56.8%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6071,596 38.0%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16220,598 20.2%  
Other income Rs m61386 15.8%   
Total revenues Rs m4,22320,984 20.1%   
Gross profit Rs m1972,818 7.0%  
Depreciation Rs m32642 4.9%   
Interest Rs m301,593 1.9%   
Profit before tax Rs m197969 20.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-138 -52.6%   
Profit after tax Rs m1241,107 11.2%  
Gross profit margin %4.713.7 34.6%  
Effective tax rate %37.0-14.3 -259.0%   
Net profit margin %3.05.4 55.4%  
BALANCE SHEET DATA
Current assets Rs m1,62918,877 8.6%   
Current liabilities Rs m1,05811,896 8.9%   
Net working cap to sales %13.733.9 40.5%  
Current ratio x1.51.6 97.0%  
Inventory Days Days3036 82.9%  
Debtors Days Days34198 17.0%  
Net fixed assets Rs m5569,861 5.6%   
Share capital Rs m78341 22.8%   
"Free" reserves Rs m87812,331 7.1%   
Net worth Rs m1,06916,139 6.6%   
Long term debt Rs m1594,706 3.4%   
Total assets Rs m2,39933,146 7.2%  
Interest coverage x7.61.6 471.3%   
Debt to equity ratio x0.10.3 50.9%  
Sales to assets ratio x1.70.6 279.1%   
Return on assets %6.48.1 78.7%  
Return on equity %11.66.9 168.9%  
Return on capital %18.512.3 150.1%  
Exports to sales %0.821.4 3.7%   
Imports to sales %1.415.2 9.2%   
Exports (fob) Rs m334,402 0.7%   
Imports (cif) Rs m583,136 1.9%   
Fx inflow Rs m334,402 0.7%   
Fx outflow Rs m633,184 2.0%   
Net fx Rs m-301,219 -2.5%   
CASH FLOW
From Operations Rs m1272,437 5.2%  
From Investments Rs m-146-6,265 2.3%  
From Financial Activity Rs m222,490 0.9%  
Net Cashflow Rs m3-1,337 -0.2%  

Share Holding

Indian Promoters % 65.4 82.7 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.3 86.0%  
FIIs % 5.2 5.5 94.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 7.5 344.0%  
Shareholders   12,723 10,665 119.3%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PANACEA BIOTECH  BIOCON LTD  FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 17, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - AUROBINDO PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS